Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors

Author(s):
Verhoef, D.; Visscher, K.M.; Vosmeer, C.R.; Cheung, K.L.; Reitsma, P.H. (0000-0003-2207-1830); Geerke, D.P.; Bos, M.H.A. (0000-0002-8164-817X)
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-09-13
Language
English
Is part of
Nature Communications
hdl
1887/115896
doi
10.1038/s41467-017-00647-9